Alzheimer Disease Clinical Trial
Official title:
Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases
Apathy, defined as a lack of motivation in behaviour, cognition and affect, is common in
neurodegenerative diseases. Specific scales are available for the evaluation of apathy but
it lacks objective evaluation methods.
The aim of this study is to evaluate the changes in reaction time task according to the
presence or absence of reward stimulation and to assess the relation between these
performances and apathy scales.
MATERIAL: 13 patients with Mild Cognitive Impairment (MCI), 15 patients with Alzheimer's
disease (AD) and 91 elderly healthy subjects were enrolled. A computerized test using the
experiment software E-prime® was designed to assess reaction times (in ms) in different
experimental conditions after a training trial (neutral, stimulation, stress, stimulation
after stress, extinction) and relation between the performances to the test and the Apathy
Inventory (AI) scores (lack of initiative, lack of interest, emotional blunting) were
observed.
METHOD: Using a computerized test, each patient is asked to press a button (mouse of the
computer) each time the screen of the computer becomes completely white. After pressing the
button, a randomized colorized geometric figure appears on the screen, and disappears
automatically after a few seconds, replaced by a new white screen. Reaction time (in ms)
between a white screen and a press of the button is analysed. After a training trial,
reaction times are analysed in different experimental conditions: neutral - stimulation1
(patient gets points when pressing the button) - stress (alarm) - stimulation2 (patient gets
points when pressing, after the stress trial) - extinction (similar to neutral condition).
;
Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |